NYSE : MCK
McKesson Corporation — Key statistics
Healthcare · Medical Distribution · United States
Last price 980.88 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 114.36B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 115.96B |
| Enterprise Value | 122.59B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Dec 1, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 116.59M |
| Shares Outstanding | 116.59M |
| Shares Change (YoY) | -3.37% |
| Shares Change (QoQ) | -2.85% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 91.96% |
| Float | 116.40M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 26.53 |
| Forward PE | 21.37 |
| PS Ratio | 0.28 |
| Forward PS | 0.26 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 18.07 |
| P/OCF Ratio | 16.92 |
| PEG Ratio | 1.68 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 26.70 |
| EV / Sales | 0.30 |
| EV / EBITDA | 17.34 |
| EV / EBIT | 19.04 |
| EV / FCF | 19.11 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.89 |
| Quick Ratio | 0.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | 1.55 |
| Debt / FCF | 1.84 |
| Interest Coverage | 23.41 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 4.74% |
| Return on Invested Capital (ROIC) | 31.75% |
| Return on Capital Employed (ROCE) | 35.81% |
| Weighted Average Cost of Capital (WACC) | 5.43% |
| Revenue Per Employee | $9.56M |
| Profits Per Employee | $106,791 |
| Employee Count | 43,000 |
| Asset Turnover | 4.85 |
| Inventory Turnover | 15.43 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.16B |
| Effective Tax Rate | 17.93% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +23.15% |
| 50-Day Moving Average | 922.19 |
| 200-Day Moving Average | 862.63 |
| Relative Strength Index (RSI) | 60.66 |
| Average Volume (20 Days) | 682,062 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.30M |
| Short Previous Month | 2.90M |
| Short % of Shares Out | 1.97% |
| Short % of Float | 1.97% |
| Short Ratio (days to cover) | 2.80 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 410.98B |
| Gross Profit | 14.93B |
| Operating Income | 6.44B |
| Pretax Income | 6.46B |
| Net Income | 4.59B |
| EBITDA | 7.07B |
| EBIT | 6.44B |
| Earnings Per Share (EPS) | $37.48 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 5.16B |
| Total Debt | 11.80B |
| Net Cash | -6.63B |
| Net Cash Per Share | -$56.88 |
| Equity (Book Value) | -1.30B |
| Book Value Per Share | -36.55 |
| Working Capital | -7.52B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 6.85B |
| Capital Expenditures | -437.00M |
| Depreciation & Amortization | 634.00M |
| Net Borrowing | 2.01B |
| Free Cash Flow | 6.42B |
| FCF Per Share | $55.03 |
Margins
| Measure | Value |
|---|
| Gross Margin | 3.63% |
| Operating Margin | 1.57% |
| Pretax Margin | 1.57% |
| Profit Margin | 1.12% |
| EBITDA Margin | 1.72% |
| EBIT Margin | 1.57% |
| FCF Margin | 1.56% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $3.76 |
| Dividend Yield | 0.38% |
| Dividend Growth (YoY) | 15.03% |
| Years of Dividend Growth | 18 |
| Payout Ratio | 10.03% |
| FCF Payout Ratio | 6.83% |
| Buyback Yield | 3.37% |
| Shareholder Yield | 3.75% |
| Earnings Yield | 3.77% |
| FCF Yield | 5.53% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $1,026.07 |
| Price Target Difference | 3.17% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 7.01% |
| EPS Growth Forecast (3Y) | 13.93% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jan 5, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 5.81 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |